Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pilot randomised controlled trial evaluating feasibility, safety and adherence to psyllium husk in peritoneal dialysis: The FIBRE-PD trial.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

Procedure-related PD-peritonitis following gastroscopy and colonoscopy: A 15-year binational data-linkage study from Australia and New Zealand.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

Effect of Hemodiafiltration and Hemodialysis on Postoperative Mortality in Patients With Kidney Failure.

Hemodialysis international. International Symposium on Home Hemodialysis·2026
Same author

Patient and nurse trainer perspectives on a structured PD training programme: A process evaluation of the TEACH-PD feasibility trial.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

End Point Selection in ADPKD Clinical Trials.

Kidney international reports·2025
Same author

Association of autosomal dominant polycystic kidney disease (ADPKD) with cardiovascular disease and mortality in patients with treated kidney failure.

BMC nephrology·2025

Related Experiment Video

Updated: May 30, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Repeated peritoneal dialysis-associated peritonitis: a multicenter registry study.

Thulasi Thirugnanasambathan1, Carmel M Hawley, Sunil V Badve

  • 1Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|August 19, 2011
PubMed
Summary

Repeated peritonitis in peritoneal dialysis (PD) patients, defined as occurring more than 4 weeks after a prior episode, involves different microbes and outcomes. Findings suggest limiting the definition of repeated peritonitis to 6 months.

More Related Videos

Colon Ascendens Stent Peritonitis (CASP) - a Standardized Model for Polymicrobial Abdominal Sepsis
06:45

Colon Ascendens Stent Peritonitis (CASP) - a Standardized Model for Polymicrobial Abdominal Sepsis

Published on: December 18, 2010

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

Related Experiment Videos

Last Updated: May 30, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Colon Ascendens Stent Peritonitis (CASP) - a Standardized Model for Polymicrobial Abdominal Sepsis
06:45

Colon Ascendens Stent Peritonitis (CASP) - a Standardized Model for Polymicrobial Abdominal Sepsis

Published on: December 18, 2010

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Epidemiology

Background:

  • Peritonitis is a common complication of peritoneal dialysis (PD).
  • Understanding the characteristics of repeated peritonitis (occurring >4 weeks after prior episode) is crucial for patient management.
  • Previous studies have focused on early recurrences, leaving a gap in knowledge regarding later episodes.

Purpose of the Study:

  • To investigate the determinants and outcomes of repeated peritonitis compared to nonrepeated peritonitis in PD patients.
  • To analyze the microbial spectrum and clinical consequences of peritonitis episodes occurring more than 4 weeks after a previous episode.

Main Methods:

  • An observational cohort study utilized data from the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA).
  • Patients with first episodes of repeated or nonrepeated peritonitis between October 2003 and December 2007 were analyzed.
  • Repeated peritonitis was defined according to International Society of PD (ISPD) criteria.

Main Results:

  • The probability of a subsequent episode being repeated peritonitis was highest at 2 months (41%) and stabilized at 14% from 6 months onward.
  • Repeated peritonitis was independently predicted by shorter time elapsed since the prior episode (OR per day, 0.91).
  • Staphylococcus aureus and coagulase-negative staphylococcus were more frequent in repeated peritonitis, while Gram-negative, streptococcal, and fungal organisms were more common in nonrepeated episodes. Repeated peritonitis was associated with higher relapse (OR, 5.41) and lower hospitalization rates (OR, 0.63).

Conclusions:

  • Repeated and nonrepeated peritonitis episodes differ in their causative microorganisms and clinical outcomes.
  • The findings support revising the ISPD definition of repeated peritonitis to a 6-month timeframe.
  • Further research is needed to address potential confounding factors and coding biases.